Uptake of anti-retroviral therapy low in young gay men

June 4, 2014 by Fran Strachan, University of New South Wales
Uptake of anti-retroviral therapy low in young gay men
Credit: Thinkstock

Lack of social welfare support and poor clinical engagement is delaying newly diagnosed, young HIV-positive gay men from accessing the anti-retroviral therapies (ART) that could save their lives.

New research by UNSW's Centre for Social Research in Health, published in HIV Medicine, identifies the potential challenges in promoting the uptake of ART among this group of under 30-year-old men in Australia.

"Younger, recently diagnosed men are likely to feel healthier and be free of HIV symptoms compared to their older HIV-positive peers, making them less inclined to begin treatment and this decision is often supported by their clinician," said lead researcher Dr Limin Mao.

"Young often aren't ready to commit to life-long treatment and its potential side-effects immediately after receiving their HIV diagnosis."

The study was based on responses from 1,911 HIV-positive men who participated in the Gay Community Period Surveys across six states and territories between 2010 and 2012.

Dr Mao said the cost of obtaining ART drugs could also be prohibitive to people with HIV even if they are covered by Medicare and warns that the proposed introduction of GP co-payments will further impact on ART uptake.

"ART is heavily subsidised by the Australian government, but there is still an up-front drug co-payment that's required. This, combined with the travel costs of getting to a clinic regularly for prescriptions is expensive," she said.

"HIV is still a highly stigmatised disease – many newly diagnosed people, particularly those who are employed, find it hard to combine regular visits to clinics and pharmacies with work," said Dr Mao.

"Coping with life-long ART use without disclosing HIV status in the workplace can be very difficult."

Uptake of routine annual STI testing – an indication of good clinical care in HIV management – is also low in gay men not using ART, suggesting they are not accessing quality clinical services.

Dr Mao recommends that more guidance and support should be provided to newly diagnosed young gay men, so they can access better clinical care and social support across the spectrum of issues around living with HIV.

"People shouldn't be simply coerced into initiating a life-long treatment without having the appropriate financial, clinical and social support," said Dr Mao.

Explore further: Focus on undiagnosed HIV

More information: Mao, L., de Wit, J., Kippax, S., Prestage, G. and Holt, M. (2014), "Younger age, recent HIV diagnosis, no welfare support and no annual sexually transmissible infection screening are associated with nonuse of antiretroviral therapy among HIV-positive gay men in Australia." HIV Medicine. DOI: 10.1111/hiv.12169

Related Stories

Focus on undiagnosed HIV

January 20, 2014
A new study that aims to identify rates of undiagnosed HIV in Australia's gay community will offer free testing across six states and territories, including at Sydney's Gay and Lesbian Mardi Gras.

Unprotected sex among young gay men on the rise

October 21, 2013
Unprotected sex with casual partners - one of the key drivers of HIV transmission among gay men - has risen significantly for those aged under 25.

Gay men divided over use of HIV prevention drug

April 6, 2014
A drug hailed as a lifesaver for many people infected by HIV is at the heart of a rancorous debate among gay men, AIDS activists and health professionals over its potential for protecting uninfected men who engage in gay ...

Younger people, men and those without children more likely to drop out of HIV care in South Africa

February 20, 2014
Analysis carried out by an academic at Royal Holloway, University of London has revealed that younger people, men and those without children are more likely to stop attending clinics for HIV treatment in South Africa.

Good news for HIV treatment as prevention

March 7, 2014
The Kirby Institute at UNSW Australia welcomes early results from the PARTNER study, which has found that HIV positive gay men who are on treatment and have undetectable viral load are not transmitting HIV to their partners.

In Africa, STI testing could boost HIV prevention

May 28, 2014
To maximize HIV prevention efforts in South Africa and perhaps the broader region, public health officials should consider testing for other sexually transmitted infections when they test for HIV, according to a new paper ...

Recommended for you

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.